Table 8 HoloTC reference intervals and cut-offs

Abbott Laboratories (2006)

37

Abbott Laboratories (2011)

35

Al Aisari et al. (2010)

9–123

Aparicio-Ugarriza et al. (2014)

20–50 (literature review)

Augoustides-Savvopoulou et al. (2007)

35

Axis-Shield and Abbott Laboratories (2006a)

35

Axis-Shield (2007a)

35

Axis-Shield (2007b)

37

Bamonti et al. (2010)

40

Black et al. (2006)

23–100

Brady et al. (2007)

35

Chen et al. (2005)

46–356

30

Clarke et al. (2007)

45

Fragasso et al. (2012)

35

Goringe et al. (2006)

16 (diagnostic), 38 (laboratory)

Green (2007, 2011)

35

Heil et al. (2012)

32

Herbert (1987)

22

Herbert (1994)

37

Herrmann et al. (2003a, b, 2005)

35

Herrmann and Obeid (2007)

40–70 “Grey zone”

Herrmann and Obeid (2008)

35

Herrmann and Obeid (2013)

22–76 “Grey zone”

Herrmann et al. (2003a)

35

Herrmann et al. (2005)

35

Hooshmand et al. (2012)

35

Hvas and Nexo (2003)

50

Hvas and Nexo (2005)

40

Lee et al. (2009)

42.48

Lindemans et al. (2007)

20–122

Lindgren et al. (1999)

35–160

Lloyd-Wright et al. (2003)

<25 likely, >50 unlikely B₁₂ deficiency

Lobreglio et al. (2008)

35

Loikas et al. (2003, 2007a, b)

37

Loikas (2007)

37–171

Miller et al. (2006)

35

Morkbak et al. (2005)

40, 11–41 (literature review)

37

Morkbak et al. (2007)

40–150

Nexo et al. (2002a)

40–150

Nexo et al. (2002b)

40–150

Nexo and Hoffmann-Lücke (2011)

40–200

Obeid and Herrmann (2007a, 2007b)

35

Palacios et al. (2013)

35

Pry (2006)

37

Refsum et al. (2006)

42–157

Remacha et al. (2014)

33.5

Schrempf et al. (2011)

42

Serefhanoglu et al. (2008)

37

Sobczyńska-Malefora et al. (2014)

25–50 “poor predictor MMA”

Valente et al. (2011)

20–30 “indeterminate zone”

20

van Asselt et al. (2003)

38–113

Vanpoucke et al. (2007)

37

Woo et al. (2010)

35